Advertisement
Screener

Gartner, Inc. (IT) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets

3.2 / 5 stars · 76/120 Roast Me

Gartner, Inc. Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets

Gartner, Inc. (IT) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets of 3.79% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets · last filed 2026-02-12

  • Gartner, Inc. defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2025 was 3.79%, a 5.57% increase from fiscal 2024.
  • Gartner, Inc. defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2024 was 3.59%, a 7.95% decline from fiscal 2023.
  • Gartner, Inc. defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2023 was 3.90%, a 146.84% increase from fiscal 2022.
  • Gartner, Inc. defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2022 was 1.58%, a 32.77% increase from fiscal 2021.
Period endDefined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets 12 month
2025-12-313.79%
10-K · filed 2026-02-12
2024-12-313.59%
10-K · filed 2026-02-12
2023-12-313.90%
10-K · filed 2026-02-12
2022-12-311.58%
10-K · filed 2025-02-13
2021-12-311.19%
10-K · filed 2024-02-15
2020-12-312.04%
10-K · filed 2023-02-16
2019-12-312.54%
10-K · filed 2022-02-23
2018-12-312.45%
10-K · filed 2021-02-24
2017-12-312.22%
10-K · filed 2020-02-19
2016-12-312.70%
10-K · filed 2017-02-22
2015-12-312.70%
10-K · filed 2016-02-24
2014-12-312.70%
10-K · filed 2015-02-27
2013-12-313.80%
10-K · filed 2014-02-26
2012-12-313.60%
10-K · filed 2013-02-22
2011-12-314.10%
10-K · filed 2012-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Evolent Health, Inc. (EVH)United States$0.397B-1.21
FRANKLIN COVEY CO (FC)United States$0.195B123.76